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Abstract Two genes (ace-I and ace-2) encode two major classes 
(A and B) of acetylcholinesterase (ACHE) in the nematode Caen- 
orhabditis elegans. A null mutation in ace-1 (allele p1000) sup- 
presses all acetylcholinesterase activity of class A. We have iden- 
tiffed an opal mutation TGG (W99)--~ TGA (Stop) as the only 
alteration in the mutated gene. This leads to a truncated protein 
(98 instead of 620 amino acids) with no enzymatic activity. The 
mutation also reduces the level of ace-1 transcripts to only 10% 
of that in wild-type animals. This most likely results from a 
destabilization of mRNA containing the nonsense message. In 
contrast, compensation of class B by class A AChE in the null 
mutant strain ace-2 takes place with unchanged ace-1 mRNA 
level and enzymatic activity similar to class A ACHE. 
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folding of the protein during maturation at the non-permissive 
temperature. In insects, homozygous null mutations in the 
AChE gene are lethal and are eliminated. In C. elegans, ho- 
mozygous null mutations in either ace-1 or ace-2 have been 
isolated [3,4]. They have no visible phenotype because of a 
functional overlap of Class A and B AChEs [4]. The null muta- 
tion in ace-1 (allele plO00) was originally identified by the total 
absence in mutants of any AChE resistant o deoxycholate (a 
property of class A AChE only, [3]). We report here the charac- 
terization of this null mutation and its effects on the level of 
ace-1 transcripts. Levels of ace-1 transcripts and class A AChE 
activity were also studied in the null mutant ace-2 to test 
whether compensation of class B by class A AChE was accom- 
panied by an over-expression of the intact gene. 
2. Materials and methods 
1. Introduction 
Acetylcholinesterase (ACHE, EC 3.1.1.7) is an essential en- 
zyme responsible for the hydrolysis of acetylcholine and thus 
for the termination of transmission at cholinergic synapses. 
There is only one gene coding for AChE in vertebrates [1] and 
insects [2]. In the nematode Caenorhabditis elegans, three genes 
(ace-l, ace-2 and ace-3) encode three classes of AChE differing 
in their catalytic properties and called AChE of class A, B and 
C, respectively [3-5]. Classes A and B are major components 
that each account for approximately half the total AChE activ- 
ity [3,4], whereas ace-3 is a minor component [5] which is, 
however, able to maintain alive the double homozygous mutant 
ace-l/ace-2 [5]. 
Only one mutation has been identified so far in human AChE 
[6] that replaces codon 322 CAC (His) by AAC (Asn). This 
mutation has no effect on enzyme activity [7] but the wild-type 
sequence is the YT1 blood group antigen and the variant with 
Asn 322 is the YT2 antigen [6]. A number of mutations in the 
locus ace of Drosophila have been reported [8]. Some are non- 
conditionally lethal and others are lethal only at some temper- 
atures [9,10]. Two mutations responsible for cold- and heat- 
sensitive phenotypes (Ace 1j29 and ace lj4° [10]) were shown to 
result from point mutations changing Ser 374 to Phe and Pro 75 
to Leu, respectively [I 1]. These mutations most likely affect 
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2.1. Animals and nomenclature 
Wild type C. elegans (N2 strain) as well as ace-1 and ace-2 mutants 
were provided by the Caenorhabditis Genetics Center (Saint Paul, MN). 
They were grown on Petri dishes seeded with E. coli (0P 50). ace-2 
mutants [4] were used to check whether the compensation fAChE of 
class B by class A AChE operated via an increase in gene transcription 
of ace-1. Unless otherwise stated ace-1 refers to the homozygous mu- 
tant, ace-l-lace-l-, and ace-2 to ace-2-/ace-2-. ACE-1 and ACE-2 refer 
to the proteins encoded by genes ace-1 and ace-2 (ACHE of Classes A 
and B), respectively. 
2.2. Solubilization of AChE, enzymatic assay and sucrose gradient 
centrifugation 
Worms (N2, ace-1 or ace-2) were collected from Petri dishes and 
rinsed twice in M9 medium [12]. Homogenization was performed twice 
in HSB buffer (rn/v = 1/5 for the first extraction and 1/2 for the second). 
HSB buffer contains 10 mM Tris-HC1, pH 7.0, 1 M NaC1, 0.5% 10- 
oleyl-ether (Brij 96; Sigma), 0.1 mg/ml bacitracin, 7.5 x 10 -3 TIU aprot- 
inin and 1 mM EDTA. Homogenizations were achieved through two 
successive high speed vortexings of 5 min in the presence of a half vol. 
of siliconized glass beads (400-800/2m in diameter). Homogenates were 
centrifuged for 1 h at 100,000 × g. Supernatants were assayed for AChE 
activity according to [13] using 1 mM acetylthiocholine as substrate. 
Protein content of extracts was determined by the bicinchoninic acid 
method following the manufacturer's in tructions for use (Pierce). Sed- 
imentation analyses were performed in 5 20% sucrose gradients in 10 
mM Tris-HC1 buffer, pH 7.5, containing 1 M NaC1 and a cocktail of 
antiproteolytics a  in extraction buffer and 0.5% Triton X-100. Samples 
(250 ml) were layered on 11 ml of gradient and centrifuged for 16 h at 
40,000 rpm at 4°C in a SW41 rotor (200,000 x g). 
2.3. DNA sequencing 
Total RNA from the mutant strain ace-1 were reverse transcribed 
using the reverse transcription kit from Pharmacia nd pdN6 primers. 
The entire coding sequence and portions of the 5' and 3' non-coding 
regions of ace-1 cDNA were then amplified by PCR using six pairs of 
synthetic oligonucleotides (see Fig. 1) deduced from the sequence of 
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wild-type ace-1 [14] and Taq polymerase from Promega. PCR experi- 
ments were run for 35 cycles (denaturation at 94°C for 1 min, annealing 
at 55°C for 1 min, elongation at 72°C for 1 min). PCR fragments were 
cloned in pGEM-T (Promega). Sequencing was performed using the 
dideoxynucleotide procedure of Sanger et al. [15] either with fluorescent 
dye primers for automated sequencing orwith [c~-S35]dATP and the 2.0 
Sequenase kit from USB for illustration (Fig. 3). 
2.4. Extraction of total RNA and Northern blot analysis 
Total RNA were extracted in guanidinium isothiocyanate according 
to [16], electrophoresed in formaldehyde-containing 1% agarose gels, 
and transferred to nylon membrane (Hybond N; Amersham). Mem- 
branes were prehybridized and hybridized at 42°C as described previ- 
ously [14] with 10 6 cpm/ml ofa 2 kb PstI fragment of ace-1 cDNA (see 
Fig. 1) labeled by random priming. The same membranes were then 
rehybridized with a C. elegans actin cDNA (gift of Lisa Matthews, 
CRBM, Montpellier). This probe was used to calibrate the amounts of 
RNA loaded. Autoradiograms were densitometrically scanned with an 
Apple OneScanner (300 dpi) coupled to an image processing and anal- 
ysis program. 
3. Results 
We first studied the effects of null mutations in either ace-1 
or ace-2 on total AChE activity and molecular forms. The 
growth of both mutant strains was apparently similar to that 
of the N2 strain. After two successive homogenizations in HSB 
buffer each followed by 1 h centrifugation at 100,000 × g, spe- 
cific AChE activity was estimated for each strain. Table 1 shows 
that each mutation roughly resulted in a reduction of 50% in 
AChE specific activity. These results are in good agreement 
with those previously reported by Culotti et al. [4] and confirm 
that ace-1 and ace-2 genes both account for approximately half 
of the total AChE activity. In addition it shows that a deficiency 
of either ace-1 or ace-2 does not induce over-expression f the 
remaining enzyme. AChE activity due to the third gene, ace-3, 
as measured in the double homozygous mutants ace-1/ace-2, 
was almost undetectable under our conditions (not shown). 
The molecular forms of AChE were analyzed by sucrose 
gradient centrifugation. Fig. 2 shows the comparison of sedi- 
mentation profiles of AChE in N2 and ace-1 (Fig. 2A) and 
between N2 and ace-2 (Fig. 2B). This analysis hows that ACE- 
1 (the enzyme absent in ace-1 mutants but responsible for 
AChE activity in ace-2 mutants) was essentially composed of 
fast sedimenting forms. One major peak of AChE activity at 
13.5 S with a shoulder at 11.5 S was observed, with a small 
amount of 4.5-5 S forms. ACE-2 was composed only of two 
peaks of slow-sedimenting forms (4.5 S and 7 S). It has been 
shown that for ACE-l ,  the 13.5 S form is a complex tetrameric 
structure that associates four catalytic subunits with a non 
catalytic element, whereas the 11.5 S peak is a (simple) ho- 
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Table 1 
Amount of AChE activity solubilized from N2, ace-1 and ace-2 strains 
Strains Extracts AChE Proteins Specific 
activity (mg/ml) AChE activity 
(OD/mn/ml) (OD/mn/mg) 
N2 1 5.6 10.6 0.53 
2 4.0 2.9 1.34 
ace-I 1 1.0 4.1 0.24 
2 0.6 0.8 0.75 
ace-2 1 1.5 5.8 0.26 
2 0.7 1.2 0.58 
Two successive xtractions in HSB buffer were performed (rn/v = 1/5 
for the first extract and 1/2 for the second). AChE activity (in OD/ml/ 
min), protein content (mg/ml) and AChE specific activity (OD/min/mg) 
are indicated. Extracts were performed with pooled worms from three 
different Petri dishes for each strain. 
motetrameric form. For ACE-2, the 7 S and 4.5 S forms are, 
respectively, dimers and monomers of the catalytic subunit 
[17-19]. 
The ace-1 null mutant was originally isolated by Johnson et 
al. [3] after ethylmethanesulfonate treatment (exposure to 
0.1 M EMS for 4 h at 20°C). EMS treatment is known to induce 
mostly point mutations (GC-to-AT transitions), although small 
deletions can also be generated [12]. We have recently reported 
the complete coding sequence of the class A AChE catalytic 
subunit in wild-type C. elegans [14]. Sequencing the mutant 
ace-1 showed only one point mutation that changed the codon 
TGG of W99 into TGA (Stop). This opal mutation was first 
found by automatic sequencing of PCR fragments obtained 
from ace-1 mRNAs in three independent experiments and was 
then confirmed in genomic DNA of the mutant (one experi- 
ment). Sequencing of this region with radiolabeled ATP is 
shown in Fig. 3. Translation of this transcript would result in 
a truncated protein (98 amino acids instead of 620 [14]) devoid 
of enzymatic activity. 
We compared the amounts of ace-1 mRNA present in N2, 
ace-1 and ace-2 strains by Northern blot analysis (Fig. 4a). An 
actin probe was used for calibration (Fig. 4b). The ratio oface- I  
to actin transcripts was calculated for N2, ace-1 and ace-2 
strains by scanning Northern blots of three independent exper- 
iments. Fig. 4c shows that there was a significant (P = 0.99) 
decrease in ace-1 transcripts in the ace-1 mutant compared to 
N2 (reduction to 10% of control values). In contrast, amounts 
of ace-1 transcripts in N2 and ace-2 strains were not signifi- 
cantly different (P = 0.95). 
I----4 
100 bp 
Psfl PstI 
s_~K SI.~ 1 S.~8 .~RI R8 S10 I RI0 P2 S12 2 -~-
5' "~" "~ "~ ~ sI~E 3' 
[ S'~ ~ ~ I .~. ~ ] ace-1 eDNA R7 Ser $9 R9 ATG / STOP 
Fig. 1. Position of the 12 oligonucleotides used for PCR. Six pairs of primers were used: SI l-P2, S12 R12, $7-R7, $8-R8, $9-R9 and S10-RI0. 
The null mutation was found in $7 R7 (vertical arrow). The cDNA probe used in Northern blot analysis is the 2 kb PstI fragment. SK, bluescript 
vector. 
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Fig. 2. Sucrose gradient analysis of AChE molecular forms in N2 (,), ace-1 and ace-2 strains (e). N2/ace-1 and N2/ace-2 comparisons are shown 
in A and B for clarity. Worm extraction was performed in HSB buffer and centrifugation in HST buffer. Vertical arrows show positions of alkaline 
phosphatase (6.1 S) and fl-galactosidase (16 S). 
4. D iscuss ion 
We report that the allele plO00 responsible for a null muta- 
tion in the ace-1 gene of C. elegans [3] corresponds to a G--*A 
transition at the third base in codon W99. The transition gener- 
ates a stop codon (TGG~TGA,  opal mutation) and the trans- 
lation of the resulting transcript leads to a truncated protein of 
98 amino acids with no enzymatic activity. This explains the 
total lack of class A AChE in ace-1 mutants. 
It should be noted that besides the present opal transition 
TGG~TGA (Stop), any other point mutation in the 
codon TGG (W99) should also have led to an inactive ACHE. 
W99 (that corresponds to W84 and W86 in Torpedo and human 
AChEs, respectively [14]) is essential for enzymatic activity 
since it corresponds to the binding site of the choline moiety 
of acetylcholine. Directed mutagenesis ofW86 in human AChE 
(that replaces W by A or E) resulted in no activity [20,21]. 
We observed that the level of ace-1 mRNAs bearing the 
premature stop codon was reduced to 10% of that in N2 strain. 
This reduction most likely results from a reduced stability of 
nonsense messengers, asshown originally in yeast [22,23]. RNA 
stability depends both upon cis- and trans-acting factors 
[23,24]. Such trans-acting factors are in the process of being 
identified in C. elegans: a series of six genes (smg genes) are 
necessary to encode a surveillance system which is responsible 
for the rapid degradation of messengers with a premature trans- 
lational termination [25]. For example, a stop codon introduced 
early in the coding sequence of unc-54, the gene encoding a 
myosin heavy chain in C. elegans, leads to a rapid degradation 
of transcripts in smg + animals but not in smg- ones [26]. Prod- 
ucts of smg genes are probably responsible for the reduced 
stability of ace-1 transcripts in the mutant. 
In the ace-2 mutant (lacking class B ACHE) both the level of 
ace-I transcripts (Fig. 4) and ACE-1 activity (Table l) were not 
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Fig. 3. Autoradiograms of sequencing gels in the region of W99 of ACE-1. N2, wild-type animals; the sequence shown corresponds toT(97)-N(102). 
ace-1 , homozygous mutant. The sequences shown are identical except for the mutation G--->A (arrow in aee-I indicates the new A, arrow in N2 
shows the original G). This transition introduces a premature stop codon, TGA, in place of the TGG codon of W99 in ACE-1. 10 ,ug of plasmid 
and 1 pmol of primer were used for each sequencing reaction. 
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Fig. 4. Northern blot analysis of ace-1 transcripts inN2, ace-1 and ace-2 
mutants. (a) Hybridization of total RNA with an ace-I cDNA probe 
(PstI PstI fragment of 2 kb, see Fig. 1). Only one transcript of 2.6 kb 
is detected. (b) Rehybridization of the same blot with an actin probe. 
The single transcript at 1.6 kb is used for calibration of amounts of 
RNA loaded. (c) Results of densitometric s ans of three independent 
Northern blot analyses. Vertical bars indicate standard deviations 
(S.D.). The ratio of ace-1 to actin signals were calculated for each strain 
in each experiment. Means and S.D. are calculated from three experi- 
ments. The asterisk indicates that the difference is significant 
(P -- 0.99). 
significantly increased compared to N2. Thus the functional 
compensation of class B by class A AChE does not require the 
over-expression of ace-1. This also tends to indicate that the 
normal amount of  AChE in wild-type C. elegans largely exceeds 
functional requirements. It is interesting to relate this conclu- 
sion to a similar situation observed in Drosophila where it is 
possible to rescue null mutants in the ace locus by transfection 
of a minigene that produces only 20-30% of the AChE activity 
found in wild-type flies [27]. 
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